GB1171619A - Vaccine adjuvants - Google Patents

Vaccine adjuvants

Info

Publication number
GB1171619A
GB1171619A GB1332266A GB1332266A GB1171619A GB 1171619 A GB1171619 A GB 1171619A GB 1332266 A GB1332266 A GB 1332266A GB 1332266 A GB1332266 A GB 1332266A GB 1171619 A GB1171619 A GB 1171619A
Authority
GB
United Kingdom
Prior art keywords
sulphonate
phenoxyethyl
nhr
march
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1332266A
Other languages
English (en)
Inventor
Harold Francis Hodson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB44453/61A external-priority patent/GB1003889A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB1332266A priority Critical patent/GB1171619A/en
Priority to CH404967A priority patent/CH544742A/de
Priority to FR100002A priority patent/FR92830E/fr
Priority to BE696102D priority patent/BE696102A/xx
Priority to CA986208A priority patent/CA921049A/en
Priority to FR111445A priority patent/FR6597M/fr
Publication of GB1171619A publication Critical patent/GB1171619A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1332266A 1961-12-12 1966-03-25 Vaccine adjuvants Expired GB1171619A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB1332266A GB1171619A (en) 1961-12-12 1966-03-25 Vaccine adjuvants
CH404967A CH544742A (de) 1961-12-12 1967-03-21 Verfahren zur Herstellung von Guanidinen
FR100002A FR92830E (fr) 1961-12-12 1967-03-23 Préparation de nouvelles guanidines, iso-urées et iso-thio-urées douées en particulier d'une activité biologique.
BE696102D BE696102A (enrdf_load_stackoverflow) 1961-12-12 1967-03-24
CA986208A CA921049A (en) 1966-03-25 1967-03-25 Guanidines and thioureas
FR111445A FR6597M (enrdf_load_stackoverflow) 1961-12-12 1967-06-22

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB44453/61A GB1003889A (en) 1961-12-12 1961-12-12 Guanidines and isothioureas
GB1332266A GB1171619A (en) 1961-12-12 1966-03-25 Vaccine adjuvants

Publications (1)

Publication Number Publication Date
GB1171619A true GB1171619A (en) 1969-11-26

Family

ID=26249709

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1332266A Expired GB1171619A (en) 1961-12-12 1966-03-25 Vaccine adjuvants

Country Status (4)

Country Link
BE (1) BE696102A (enrdf_load_stackoverflow)
CH (1) CH544742A (enrdf_load_stackoverflow)
FR (2) FR92830E (enrdf_load_stackoverflow)
GB (1) GB1171619A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
FR6597M (enrdf_load_stackoverflow) 1969-01-06
BE696102A (enrdf_load_stackoverflow) 1967-09-25
FR92830E (fr) 1969-01-03
CH544742A (de) 1974-01-15

Similar Documents

Publication Publication Date Title
ES409907A1 (es) Procedimiento para la preparacion de imidazolil-(2)-carbi- noles.
PT86376A (en) Process for the preparation of an adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
GB1206491A (en) PROCESS FOR PREPARING NITRO-p-PHENYLENEDIAMINES
GB1292803A (en) Improvements relating to the production of antigens
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
BE750349A (fr) Vaccin destine a l'immunisation active comprenant comme adjuvant le diethylaminoethyldextrane
GB1171619A (en) Vaccine adjuvants
FR2303562A1 (fr) Nouvelle preparation d'antigene utilisable comme vaccin
GB1089767A (en) Vaccine adjuvants
GB1213361A (en) Quaternary ammonium compounds
GB1051870A (enrdf_load_stackoverflow)
BE834754R (fr) Agents adjuvants formes par des derives de l'acide n-acyl-muramique et compositions de vaccins contenant ces agents adjuvants
ES262654A1 (es) Un metodo para hacer preparaciones inmunizantes
GB1255751A (en) Herbicidal agents
ES393894A1 (es) Procedimiento para la obtencion de 1-metil-3- ((p-metil- alfa-fenil-bencil) oximetil) piperidina y sus sales de adi- cion y de amonio cuaternario.
GB1132287A (en) Antibiotic compositions
IT1054551B (it) Concentrati emulsionati stabili alla conservazione di biocidi sen sibili all idrolisi
GB1342232A (en) Aryliminothiazolidines a process for their preparation and their use as acaricides
GB1073521A (en) Indole derivatives
GB794798A (en) Pharmaceutical compositions
ES266340A1 (es) Procedimiento para la preparaciën de vacunas poliemieliticas
GB1265930A (enrdf_load_stackoverflow)
OA00849A (fr) Procédé de préparation d'un vaccin contre le trachome.
GB1077723A (en) Preparation for the care of the skin
GB1378469A (en) Phosphonic acid ester amides a process for their preparation and their use as nematicides